Merck (MRK) Tops Q3 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Merck (MRK) tops Q3 expectations on sustained growth in oncology and vaccine segments
October 26, 2023 9:26 AM EDTMerck (NYSE: MRK) reported earnings before the open Thursday, topping both profit and revenue consensus expectations.
The pharmaceutical company reported earnings of $2.13 per share, $0.18 better than the analyst estimate of $1.95, while revenue for the quarter came in at $16 billion, up 7% YoY and above the consensus estimate of $15.29 billion.
The company... More
